United Kingdom · Venture startup

Who invested in Amber Therapeutics

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$102Mraised across 2 rounds since 2024, from 2 sources

Latest round
VentureMar 2026
Biggest round
$102MSeries A · Jun 2024
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026
$102MSeries A?Venture
First round
Series A, $102M
Jun 2024
Biggest round
$102M
Series A · Jun 2024
Between rounds
21 months
from the last two

The rounds

  1. Mar 2026
    VentureAmount undisclosed3 returning

    Source recorded

  2. Jun 2024

Funding filed with regulators

Amber Therapeutics filed one raise, $38M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Oct 2025$38MUK share allotment

Founders and team

From Amber Therapeutics's own website: 4 founders, 2 on the team.

Aidan CrawleyCo-founder & CEO
Charles KnowlesCo-founder & CMO
Stefan De WachterCo-founder & Chief Scientist
Tim DenisonCo-founder & Chief Engineer
  • Tomás FureyVP Operations
  • Dave AmersonIndependent Director

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

8VCVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Amber Therapeutics

Who invested in Amber Therapeutics?

Amber Therapeutics's investors include New Enterprise Associates, 8VC and Oxford Science Enterprises.

How much has Amber Therapeutics raised?

Amber Therapeutics has raised $102M across 2 rounds since 2024. One round did not disclose an amount, so the total is a floor.

When did Amber Therapeutics last raise?

Amber Therapeutics's most recent round was a Venture in Mar 2026.

What was Amber Therapeutics's biggest round?

Amber Therapeutics's largest round on record is $102M (Series A), in Jun 2024.

Who backed Amber Therapeutics first?

Amber Therapeutics's first round on record, in Jun 2024, was backed by New Enterprise Associates, 8VC and Oxford Science Enterprises.

What stage is Amber Therapeutics at?

Amber Therapeutics's latest named round is a Venture, in Mar 2026.

Where is Amber Therapeutics based?

Amber Therapeutics is based in the United Kingdom.

Companies like Amber Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.